ThursdayJul 09, 2026 10:00 am

Bitcoin ETFs Record First Half-Year of Net Outflows

Bitcoin spot exchange-traded funds posted their first negative six-month performance since entering the market, marking a notable shift after a prolonged period of consistent investor inflows. DWF Labs data shows that Bitcoin spot ETFs finished the first half of the year with net withdrawals totaling $5.4 billion. The decline follows two years of sustained demand that had pushed cumulative net inflows to $56.6 billion by the beginning of 2026. January alone recorded $1.6 billion in net outflows, and by February 23, total cumulative inflows had dropped to $53.8 billion. That represented a decline of $2.8 billion in under two months.…

Continue Reading

WednesdayJul 08, 2026 10:30 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

The company has initiated cell line development for its lead BiTAC(R) T-cell engager program, selecting ATUM to support manufacturing development as the candidate advances toward IND/CTA-enabling studies. ATUM will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines for VERAXA's lead therapeutic candidate. The collaboration represents an important development milestone, supporting manufacturing, analytical development and nonclinical studies required before clinical testing. VERAXA's BiTAC(R) platform is designed to improve the selectivity of T-cell engagers, potentially reducing toxicity associated with conventional approaches. The company recently expanded its research facilities in Heidelberg, Germany, increasing laboratory capacity as multiple oncology programs move…

Continue Reading

TuesdayJul 07, 2026 10:00 am

France to Relaunch its Social Leasing EV Program in July

France will relaunch the country’s social leasing electric vehicle (EV) program on July 16, 2026 as part of its effort to make electric cars more affordable for lower-income workers. The program is designed to help people who rely on private vehicles for work but cannot afford the high upfront cost of buying a new EV. Instead of purchasing a car, eligible drivers can lease one at a monthly cost of less than €200 ($228), making cleaner transportation more accessible. The program is available across Metropolitan France, the country's overseas departments and regions, and Saint-Pierre-et-Miquelon. It focuses on helping workers who…

Continue Reading

MondayJul 06, 2026 10:00 am

South Korea Earmarks $1 Trillion for Chip, AI Investment

South Korea has announced one of its biggest technology investment plans ever. The country plans to spend more than $1 trillion over the coming years to strengthen its leadership in semiconductor chips and artificial intelligence (AI). The government believes this investment is necessary to stay ahead in the fast-growing global technology industry. President Lee Jae Myung introduced the plan as a major step toward securing South Korea's future. He said the country must move faster than other nations in developing the key technologies that will shape the world. The strategy focuses on three main areas: semiconductor chips, physical AI, and…

Continue Reading

ThursdayJul 02, 2026 10:00 am

Why Wall Street Watches Jefferies’ Earnings Reports Closely

Jefferies Financial may not be as large as Wall Street giants like Goldman Sachs, Morgan Stanley, or JPMorgan Chase, but its earnings reports attract plenty of attention. Many investors and market analysts watch the company's financial results because they often provide an early look at how the investment banking industry is performing. Since Jefferies reports its earnings weeks before the biggest U.S. banks, its results can offer useful clues about what may happen when those larger institutions announce their own quarterly performance. One reason Jefferies is closely followed is that its financial quarter ends earlier than those of many major…

Continue Reading

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

Continue Reading

Contact us: (512) 354-7000